BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22009011)

  • 21. [A rare thalassemia intermedia case caused by co-existence of Hb H disease (--(SEA)/-alpha(4.2)) and beta-thalassemia major (beta (CD17A)>T/beta (IVS2-654C)>T): implications for prenatal diagnosis].
    Li Q; Li LY; Mo QH
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):16-9. PubMed ID: 18227017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired immunodeficiency syndrome (AIDS) with lymphocytic interstitial pneumonitis (LIP) in a multi transfused child with thalassemia major.
    Sen S; Goyal RS; Kumar A; Pande I; Khare SD; Chattopadhya D; Malaviya AN
    Indian Pediatr; 1992 Nov; 29(11):1413-7. PubMed ID: 1294497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis--prognostic relevance is independent of IPSS or karyotype.
    Tefferi A; Siragusa S; Hussein K; Schwager SM; Hanson CA; Pardanani A; Cervantes F; Passamonti F
    Am J Hematol; 2010 Jan; 85(1):14-7. PubMed ID: 20029953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute hepatic sequestration associated with pneumococcal infection in a 5-year-old Boy with sickle beta degrees -thalassemia: a case report and review of the literature.
    Ahmed N; Chizhevsky V
    J Pediatr Hematol Oncol; 2007 Oct; 29(10):720-4. PubMed ID: 17921856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypocholesterolemia in children and adolescents with beta-thalassemia intermedia.
    Hartman C; Tamary H; Tamir A; Shabad E; Levine C; Koren A; Shamir R
    J Pediatr; 2002 Oct; 141(4):543-7. PubMed ID: 12378195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insight onto the pathophysiology and clinical complications of thalassemia intermedia.
    Cappellini MD; Musallam KM; Taher AT
    Hemoglobin; 2009; 33 Suppl 1():S145-59. PubMed ID: 20001620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving erythropoiesis: a compelling case for iron chelation in myelofibrosis.
    Pullarkat V
    Eur J Haematol; 2016 Jun; 96(6):549-50. PubMed ID: 26572646
    [No Abstract]   [Full Text] [Related]  

  • 28. Hydroxyurea in the management of thalassemia intermedia.
    Karimi M
    Hemoglobin; 2009; 33 Suppl 1():S177-82. PubMed ID: 20001623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased transfusion needs associated with hydroxyurea therapy in Algerian patients with thalassemia major or intermedia.
    Bradai M; Pissard S; Abad MT; Dechartres A; Ribeil JA; Landais P; de Montalembert M
    Transfusion; 2007 Oct; 47(10):1830-6. PubMed ID: 17880608
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thalassemia intermedia with iron deficiency.
    Panigrahi I; Das RR; Shah R; Marwaha RK
    J Pediatr Hematol Oncol; 2009 Dec; 31(12):989. PubMed ID: 19935097
    [No Abstract]   [Full Text] [Related]  

  • 31. Thalassemia intermedia.
    Camaschella C; Cappellini MD
    Haematologica; 1995; 80(1):58-68. PubMed ID: 7758995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sickle beta-thalassemia presenting as orbital compression syndrome.
    Dixit A; Chatterjee TC; Papneja M; Mishra P; Mahapatra M; Pati HP; Saxena R; Choudhry VP
    Ann Hematol; 2004 Aug; 83(8):536-40. PubMed ID: 14986068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic relevance of anemia and transfusion dependency in myelodysplastic syndromes and primary myelofibrosis.
    Pardanani A; Tefferi A
    Haematologica; 2011 Jan; 96(1):8-10. PubMed ID: 21193428
    [No Abstract]   [Full Text] [Related]  

  • 34. An unusual febrile nonhemolytic reaction occurred after transfusion in a thalassemia major patient with asymptomatic Plasmodium falciparum infection.
    Boschetti C; Cappellini MD; Colombi M; Villa A; Grande R; Vercellati C; Radaelli F; Caspani L; Zanella A
    Transfusion; 2011 Mar; 51(3):469-72. PubMed ID: 20735767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analyzing 5'HS3 and 5'HS4 LCR core regions and NF-E2 in Iranian thalassemia intermedia patients with normal or carrier status for beta-globin mutations.
    Neishabury M; Azarkeivan A; Oberkanins C; Abedini SS; Zamani S; Najmabadi H
    Blood Cells Mol Dis; 2011 Mar; 46(3):201-5. PubMed ID: 21232998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Segmental duplications involving the alpha-globin gene cluster are causing beta-thalassemia intermedia phenotypes in beta-thalassemia heterozygous patients.
    Harteveld CL; Refaldi C; Cassinerio E; Cappellini MD; Giordano PC
    Blood Cells Mol Dis; 2008; 40(3):312-6. PubMed ID: 18249014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Malaria infection after allogeneic bone marrow transplantation in a child with thalassemia.
    Tran VB; Tran VB; Lin KH
    Bone Marrow Transplant; 1997 Jun; 19(12):1259-60. PubMed ID: 9208123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelofibrosis in a case of Hb . E-beta + thalassemia disease.
    Aksoy M; Tahsinoğlu M; Erdem S; Dinçol G
    New Istanbul Contrib Clin Sci; 1978 Dec; 12(3-4):279-81. PubMed ID: 756539
    [No Abstract]   [Full Text] [Related]  

  • 39. A large splenic tumor in a patient with chronic hepatitis B and β-thalassemia.
    Yu SC
    Gastroenterology; 2012 Aug; 143(2):299-300, 506. PubMed ID: 22722046
    [No Abstract]   [Full Text] [Related]  

  • 40. The pattern of bone disease in transfusion-dependent thalassemia major patients.
    Katz K; Horev G; Goshen J; Tamary H
    Isr J Med Sci; 1994 Aug; 30(8):577-80. PubMed ID: 8045734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.